Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trialMehreen S. Datoo, Nsajigwa Misidai, Alassane Dicko et al.|The Lancet|2024Cited by 345
Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Mali: A Randomised, Double-Blind, Placebo-Controlled TrialAlassane Dicko, Brian Greenwood, Abdoulbaki I. Diallo et al.|PLoS Medicine|2011Cited by 174
Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, MaliFatou Diawara, Alassane Dicko, Erin Eckert et al.|Malaria Journal|2017Cited by 127
The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling studyNora Schmit, Peter Winskill, Hillary M. Topazian et al.|The Lancet Infectious Diseases|2024Cited by 48
Sporozoite immunization: innovative translational science to support the fight against malariaThomas L. Richie, Stephen L. Hoffman, L. W. Preston Church et al.|Expert Review of Vaccines|2023Cited by 46